Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in protein and antibody microarray technology.

Philipp Angenendt1

  • 1German Cancer Research Center, Functional Genome Analysis, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany. p.angenendt@dkfz-heidelberg.de

Drug Discovery Today
|April 6, 2005
PubMed
Summary

Genome sequencing advances enable complex sample analysis. This review covers protein and antibody microarrays for proteome characterization, discussing their potential and limitations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS.

Advances in experimental medicine and biology·2016
Same author

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686).

Clinical cancer research : an official journal of the American Association for Cancer Research·2016
Same author

Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.

Oncotarget·2015
Same author

Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.

Oncotarget·2015
Same author

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.

Clinical cancer research : an official journal of the American Association for Cancer Research·2012
Same author

Detection of tumor DNA at the margins of colorectal cancer liver metastasis.

Clinical cancer research : an official journal of the American Association for Cancer Research·2011

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genomics

Background:

  • Genome sequencing projects have advanced, shifting focus to complex sample characterization.
  • There is increasing interest in studying organisms at both genomic and proteomic levels.
  • Characterizing proteomes requires advanced analytical technologies.

Purpose of the Study:

  • To introduce protein and antibody microarray technologies.
  • To highlight the current prospects and limitations of these technologies for proteome screening.

Main Methods:

  • Review of protein and antibody microarray technologies.
  • Comparison with traditional methods like 2D gel electrophoresis and mass spectrometry.

Main Results:

Related Experiment Videos

  • Protein and antibody microarrays are promising technologies for screening complex protein samples.
  • These technologies currently face limitations that need to be addressed for successful application.

Conclusions:

  • Protein and antibody microarrays offer significant potential for proteomic studies.
  • Overcoming current limitations is crucial for the widespread adoption and success of these microarray technologies.